D C Jarlais
Biographic Data
| ID | 6072236 |
|---|---|
| NAME | D C Jarlais |
| GIVEN NAMES | D C |
| FAMILY NAME | Jarlais |
| SIGNATURE | JARLAIS D C |
| VERIFIED | No |
| TOTAL WORKS | 1 |
| TOTAL CITATIONS | 11 |
| AUTHOR COUNT | 1 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 1995 |
| LATEST PUBLICATION YEAR | 1995 |
| H-INDEX | 1 |
Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program
OBJECTIVES. This case-control study examined the association between syringe exchange use and hepatitis B and C in injection drug users. METHODS. Case patients included 28 injection drug users with acute hepatitis B and 20 with acute hepatitis C reported to the health department in a sentinel hepatitis surveillance county; control subjects were injection drug users with no markers of exposure to hepatitis B or C (n = 38 and 26, respectively) atte…
Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program
OBJECTIVES. This case-control study examined the association between syringe exchange use and hepatitis B and C in injection drug users. METHODS. Case patients included 28 injection drug users with acute hepatitis B and 20 with acute hepatitis C reported to the health department in a sentinel hepatitis surveillance county; control subjects were injection drug users with no markers of exposure to hepatitis B or C (n = 38 and 26, respectively) atte…
Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program
OBJECTIVES. This case-control study examined the association between syringe exchange use and hepatitis B and C in injection drug users. METHODS. Case patients included 28 injection drug users with acute hepatitis B and 20 with acute hepatitis C reported to the health department in a sentinel hepatitis surveillance county; control subjects were injection drug users with no markers of exposure to hepatitis B or C (n = 38 and 26, respectively) atte…
Confidence interval (1 works) · Drug (1 works) · Hepatitis (1 works) · Hepatitis B (1 works) · Hepatitis B virus (1 works) · Hepatitis B Virus Studies (1 works) · Hepatitis C (1 works) · Hepatitis C virus research (1 works) · HIV, Drug Use, Sexual Risk (1 works) · Immunology (1 works)